Metastatic Gastric Adenocarcinoma
Metastatic gastric adenocarcinoma is a type of cancer that originates in the stomach and has spread to other organs. It can cause various symptoms and requires specialized treatment.
We are exploring new personalized immunotherapy treatments for patients with advanced gastric cancer. The goal is to see if these targeted therapies can improve outcomes for those with recurrent or metastatic disease.
Health conditions and diseases that the clinical trial is designed to study and treat.
Metastatic gastric adenocarcinoma is a type of cancer that originates in the stomach and has spread to other organs. It can cause various symptoms and requires specialized treatment.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.